UNSPSC 51101691: Tenonitrozole

This classification denotes an anti-protozoal with the molecular formula C8H5N3O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PBQ7WLE1WP, chemically known as N-(5-nitro-1,3-thiazol-2-yl)thiophene-2-carboxamide but generally known as tenonitrozole, which bears US NIH Compound Identifier 19646. European Medicines Agency schedules tenonitrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10897MIG. Most nations schedule tenonitrozole under HS 29341000 and SITC 51579.

As of Q4 2014, TENONITROZOLE remains the US FDA Preferred Term for this commodity. SMILES: C1=CSC(=C1)C(=O)NC2=NC=C(S2)[N+](=O)[O-].

UNSPSC 51101691 Tenonitrozole is a Commodity-tier code that, based on recent state and local solicitations, encompasses pharmaceutical products and medical supplies procured by public health agencies, fire departments, and multistate cooperative purchasing alliances. The actual work being solicited under this code spans naloxone and drug deactivation systems for emergency response, generic pharmaceuticals and over-the-counter products for state and local health programs, and medical and first aid supplies for fire rescue operations. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The scope reflects procurement of consumable medical products, emergency pharmaceuticals, and health supplies required to support public safety and health services delivery across municipal, county, and state jurisdictions.

Recent activity spans Florida, Texas, and Minnesota, with multistate procurement vehicles extending service to Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market for Small Local Business Enterprises with an estimated contract value of $700,000 and a March 13, 2026 response deadline; Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 effective date for awarded vendors; and the Texas HHS Commission's Request for Information regarding direct-to-manufacturer prescription programs, issued in early April 2026 as a market intelligence-gathering phase ahead of formal competitive solicitation.